KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024)

Opko Health filings provide 3 years of Non-Current Deffered Revenue readings, the most recent being $7000.0 for Q3 2024.

  • On a quarterly basis, Non-Current Deffered Revenue fell 94.85% to $7000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $7000.0, a 94.85% decrease, with the full-year FY2024 number at $7000.0, changed N/A from a year prior.
  • Non-Current Deffered Revenue hit $7000.0 in Q3 2024 for Opko Health, roughly flat from $7000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $140000.0 in Q2 2023 to a low of $7000.0 in Q4 2023.
  • Median Non-Current Deffered Revenue over the past 3 years was $7000.0 (2023), compared with a mean of $63142.9.
  • The widest YoY moves for Non-Current Deffered Revenue: up 94.85% in 2024, down 95.0% in 2024.
  • Opko Health's Non-Current Deffered Revenue stood at $138000.0 in 2022, then tumbled by 94.93% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024.
  • The last three reported values for Non-Current Deffered Revenue were $7000.0 (Q3 2024), $7000.0 (Q2 2024), and $7000.0 (Q1 2024) per Business Quant data.